Steris (STE) Common Equity (2017 - 2026)

Steris' Common Equity history runs 10 years deep, the most recent figure standing at $7.2 billion for Q1 2026.

• On a quarterly basis, Common Equity rose 8.79% year-over-year to $7.2 billion in Q1 2026; TTM through Mar 2026 was $7.2 billion, a 8.79% increase from a year earlier, with the FY2026 full-year figure at $7.2 billion, up 8.79% from the prior year.
• Common Equity steadied at $7.2 billion in Q1 2026 per STE's latest filing, from $7.2 billion in the prior quarter.
• Across five years, Common Equity topped out at $7.2 billion in Q1 2026 and bottomed at $5.8 billion in Q3 2022.
• The 5-year median for Common Equity is $6.4 billion (2023), against an average of $6.5 billion.
• Biggest YoY gain for Common Equity was 68.18% in 2022; the steepest drop was 11.18% in 2022.
• Year by year, Common Equity stood at $6.0 billion in 2022, then increased by 6.46% to $6.4 billion in 2023, then rose by 0.01% to $6.4 billion in 2024, then advanced by 11.5% to $7.2 billion in 2025, then grew by 0.41% to $7.2 billion in 2026.
• Per Business Quant, the three latest STE Common Equity figures stand at $7.2 billion (Q1 2026), $7.2 billion (Q4 2025), and $7.0 billion (Q3 2025).